{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:32:49Z","timestamp":1783524769823,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology","doi-asserted-by":"crossref","award":["Program for the Strategic Research Foundation at Private Universitie"],"award-info":[{"award-number":["Program for the Strategic Research Foundation at Private Universitie"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10384-024-01106-x","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T06:02:01Z","timestamp":1725084121000},"page":"764-770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacokinetics of ganciclovir eye drops: a comparative study of solutions prepared from ganciclovir for intravenous infusion and ganciclovir gel"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2275-5263","authenticated-orcid":false,"given":"Naoki","family":"Okumura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,31]]},"reference":[{"key":"1106_CR1","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/0002-9394(82)90466-4","volume":"93","author":"AA Khodadoust","year":"1982","unstructured":"Khodadoust AA, Attarzadeh A. Presumed autoimmune corneal endotheliopathy. Am J Ophthalmol. 1982;93:718\u201322.","journal-title":"Am J Ophthalmol"},{"key":"1106_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/0002-9394(85)90811-6","volume":"100","author":"JB Robin","year":"1985","unstructured":"Robin JB, Steigner JB, Kaufman HE. Progressive herpetic corneal endotheliitis. Am J Ophthalmol. 1985;100:336\u20137.","journal-title":"Am J Ophthalmol"},{"key":"1106_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0002-9394(14)76251-8","volume":"112","author":"Y Ohashi","year":"1991","unstructured":"Ohashi Y, Yamamoto S, Nishida K, Okamoto S, Kinoshita S, Hayashi K, Manabe R. Demonstration of herpes simplex virus DNA in idiopathic corneal endotheliopathy. Am J Ophthalmol. 1991;112:419\u201323.","journal-title":"Am J Ophthalmol"},{"key":"1106_CR4","first-page":"71","volume":"190","author":"PC Maudgal","year":"1980","unstructured":"Maudgal PC, Missotten L, De Clercq E, Descamps J. Varicella-Zoster virus in the human corneal endothelium: a case report. Bull Soc Belge Ophtalmol. 1980;190:71\u201386.","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"1106_CR5","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ajo.2005.09.021","volume":"141","author":"N Koizumi","year":"2006","unstructured":"Koizumi N, Yamasaki K, Kawasaki S, Sotozono C, Inatomi T, Mochida C, Kinoshita S. Cytomegalovirus in aqueous humor from an eye with corneal endotheliitis. Am J Ophthalmol. 2006;141:564\u20135.","journal-title":"Am J Ophthalmol"},{"key":"1106_CR6","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ophtha.2006.07.057","volume":"114","author":"SP Chee","year":"2007","unstructured":"Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH. Corneal endotheliitis associated with evidence of cytomegalovirus infection. Ophthalmology. 2007;114:798\u2013803.","journal-title":"Ophthalmology"},{"key":"1106_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.ajo.2006.11.026","volume":"143","author":"A Shiraishi","year":"2007","unstructured":"Shiraishi A, Hara Y, Takahashi M, Oka N, Yamaguchi M, Suzuki T, et al. Demonstration of owl\u2019s eye morphology by confocal microscopy in a patient with presumed cytomegalovirus corneal endotheliitis. Am J Ophthalmol. 2007;143:715\u20137.","journal-title":"Am J Ophthalmol"},{"key":"1106_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/ICO.0b013e31802d82fa","volume":"26","author":"T Suzuki","year":"2007","unstructured":"Suzuki T, Hara Y, Uno T, Ohashi Y. DNA of cytomegalovirus detected by PCR in aqueous of patient with corneal endotheliitis after penetrating keratoplasty. Cornea. 2007;26:370\u20132.","journal-title":"Cornea"},{"key":"1106_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ophtha.2007.04.053","volume":"115","author":"N Koizumi","year":"2008","unstructured":"Koizumi N, Suzuki T, Uno T, Chihara H, Shiraishi A, Hara Y, et al. Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology. 2008;115:292\u20137. e3.","journal-title":"Ophthalmology"},{"key":"1106_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/08820530802111010","volume":"23","author":"T Suzuki","year":"2008","unstructured":"Suzuki T, Ohashi Y. Corneal endotheliitis. Semin Ophthalmol. 2008;23:235\u201340.","journal-title":"Semin Ophthalmol"},{"key":"1106_CR11","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ophtha.2008.10.031","volume":"116","author":"A Anshu","year":"2009","unstructured":"Anshu A, Chee SP, Mehta JS, Tan DT. Cytomegalovirus endotheliitis in Descemet\u2019s stripping endothelial keratoplasty. Ophthalmology. 2009;116:624\u201330.","journal-title":"Ophthalmology"},{"key":"1106_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ophtha.2008.09.030","volume":"116","author":"YS Hwang","year":"2009","unstructured":"Hwang YS, Hsiao CH, Tan HY, Chen KJ, Chen TL, Lai CC. Corneal endotheliitis. Ophthalmology. 2009;116:164\u2013e1641.","journal-title":"Ophthalmology"},{"key":"1106_CR13","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajo.2007.12.015","volume":"145","author":"SP Chee","year":"2008","unstructured":"Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol. 2008;145:834\u201340.","journal-title":"Am J Ophthalmol"},{"key":"1106_CR14","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1136\/bjo.2009.167767","volume":"94","author":"SP Chee","year":"2010","unstructured":"Chee SP, Jap A. Cytomegalovirus anterior uveitis: outcome of treatment. Br J Ophthalmol. 2010;94:1648\u201352.","journal-title":"Br J Ophthalmol"},{"key":"1106_CR15","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.ophtha.2006.09.035","volume":"114","author":"LA van Boxtel","year":"2007","unstructured":"van Boxtel LA, van der Lelij A, van der Meer J, Los LI. Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology. 2007;114:1358\u201362.","journal-title":"Ophthalmology"},{"key":"1106_CR16","doi-asserted-by":"crossref","unstructured":"Chee SP, Jap A. Immune ring formation associated with cytomegalovirus endotheliitis. Am J Ophthalmol. 2011;152:449\u2009\u2013\u200953.e1.","DOI":"10.1016\/j.ajo.2011.03.003"},{"key":"1106_CR17","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/bjophthalmol-2014-306486","volume":"99","author":"M Hosogai","year":"2015","unstructured":"Hosogai M, Shima N, Nakatani Y, Inoue T, Iso T, Yokoo H, et al. Analysis of human cytomegalovirus replication in primary cultured human corneal endothelial cells. Br J Ophthalmol. 2015;99:1583\u201390.","journal-title":"Br J Ophthalmol"},{"key":"1106_CR18","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/jmv.24239","volume":"87","author":"N Oka","year":"2015","unstructured":"Oka N, Suzuki T, Inoue T, Kobayashi T, Ohashi Y. Polymorphisms in cytomegalovirus genotype in immunocompetent patients with corneal endotheliitis or iridocyclitis. J Med Virol. 2015;87:1441\u20135.","journal-title":"J Med Virol"},{"key":"1106_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.exer.2017.06.017","volume":"161","author":"D Miyazaki","year":"2017","unstructured":"Miyazaki D, Uotani R, Inoue M, Haruki T, Shimizu Y, Yakura K, et al. Corneal endothelial cells activate innate and acquired arm of anti-viral responses after cytomegalovirus infection. Exp Eye Res. 2017;161:143\u201352.","journal-title":"Exp Eye Res"},{"key":"1106_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10384-018-0618-1","volume":"62","author":"D Shimizu","year":"2018","unstructured":"Shimizu D, Miyazaki D, Shimizu Y, Hosogai M, Kosugi I, Inoue Y. Infection of endotheliotropic human cytomegalovirus of trabecular meshwork cells. Jpn J Ophthalmol. 2018;62:667\u201376.","journal-title":"Jpn J Ophthalmol"},{"key":"1106_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10384-013-0268-2","volume":"57","author":"M Kandori","year":"2013","unstructured":"Kandori M, Miyazaki D, Yakura K, Komatsu N, Touge C, Ishikura R, et al. Relationship between the number of cytomegalovirus in anterior chamber and severity of anterior segment inflammation. Jpn J Ophthalmol. 2013;57:497\u2013502.","journal-title":"Jpn J Ophthalmol"},{"key":"1106_CR22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1136\/bjo.2008.156422","volume":"94","author":"M Miyanaga","year":"2010","unstructured":"Miyanaga M, Sugita S, Shimizu N, Morio T, Miyata K, Maruyama K, et al. A significant association of viral loads with corneal endothelial cell damage in cytomegalovirus anterior uveitis. Br J Ophthalmol. 2010;94:336\u201340.","journal-title":"Br J Ophthalmol"},{"key":"1106_CR23","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.survophthal.2021.12.006","volume":"67","author":"R La Distia Nora","year":"2022","unstructured":"La Distia Nora R, Putera I, Mayasari YD, Hikmahwati W, Pertiwi AM, Ridwan AS, et al. Clinical characteristics and treatment outcomes of cytomegalovirus anterior uveitis and endotheliitis: a systematic review and meta-analysis. Surv Ophthalmol. 2022;67:1014\u201330.","journal-title":"Surv Ophthalmol"},{"key":"1106_CR24","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1136\/bjophthalmol-2017-311145","volume":"102","author":"K Kitazawa","year":"2018","unstructured":"Kitazawa K, Jongkhajornpong P, Inatomi T, Koizumi N, Kayukawa K, Wakimasu K, et al. Topical ganciclovir treatment Post-descemet\u2019s stripping automated endothelial keratoplasty for patients with bullous keratopathy induced by cytomegalovirus. Br J Ophthalmol. 2018;102:1293\u20137.","journal-title":"Br J Ophthalmol"},{"key":"1106_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1442-9071.2012.02888.x","volume":"41","author":"CC Su","year":"2013","unstructured":"Su CC, Wang IJ, Chen WL, Lin CP, His B, Hu FR. Topical ganciclovir treatment in patients with cytomegalovirus endotheliitis receiving penetrating keratoplasty. Clin Exp Ophthalmol. 2013;41:339\u201347.","journal-title":"Clin Exp Ophthalmol"},{"key":"1106_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00417-011-1813-7","volume":"250","author":"SP Chee","year":"2012","unstructured":"Chee SP, Jap A. Treatment outcome and risk factors for visual loss in Cytomegalovirus Endotheliitis. Graefes Arch Clin Exp Ophthalmol. 2012;250:383\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1106_CR27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1136\/bjophthalmol-2015-308238","volume":"101","author":"N Koizumi","year":"2017","unstructured":"Koizumi N, Miyazaki D, Inoue T, Ohtani F, Kandori-Inoue M, Inatomi T, et al. The effect of topical application of 0.15% ganciclovir gel on cytomegalovirus corneal endotheliitis. Br J Ophthalmol. 2017;101:114\u20139.","journal-title":"Br J Ophthalmol"},{"key":"1106_CR28","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1073\/pnas.80.13.4139","volume":"80","author":"AK Field","year":"1983","unstructured":"Field AK, Davies ME, DeWitt C, Perry HC, Liou R, Germershausen J, et al. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication. Proc Natl Acad Sci U S A. 1983;80:4139\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1106_CR29","doi-asserted-by":"publisher","first-page":"e0191850","DOI":"10.1371\/journal.pone.0191850","volume":"13","author":"S Waduthantri","year":"2018","unstructured":"Waduthantri S, Zhou L, Chee SP. Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: a pilot study. PLoS ONE. 2018;13:e0191850.","journal-title":"PLoS ONE"},{"key":"1106_CR30","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1073\/pnas.80.9.2767","volume":"80","author":"YC Cheng","year":"1983","unstructured":"Cheng YC, Huang ES, Lin JC, Mar EC, Pagano JS, Dutschman GE, Grill SP. Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc Natl Acad Sci USA. 1983;80:2767\u201370.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1106_CR31","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2165\/00003495-199039040-00008","volume":"39","author":"D Faulds","year":"1990","unstructured":"Faulds D, Heel RC, Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs. 1990;39:597\u2013638.","journal-title":"Drugs"},{"key":"1106_CR32","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S0161-6420(87)33535-3","volume":"94","author":"DA Jabs","year":"1987","unstructured":"Jabs DA, Newman C, De Bustros S, Polk BF. Treatment of cytomegalovirus retinitis with ganciclovir. Ophthalmology. 1987;94:824\u201330.","journal-title":"Ophthalmology"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01106-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-024-01106-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01106-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T08:04:43Z","timestamp":1732867483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-024-01106-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,31]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1106"],"URL":"https:\/\/doi.org\/10.1007\/s10384-024-01106-x","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,31]]},"assertion":[{"value":"16 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N. Okumura, None; T. Tanaka, None; Y. Fukui, None; N. Koizumi, Consultant fee (M\u2019s Science Corporation, ROHTO).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}